# FDA Inspection 1006661 - Hisamitsu Pharmaceutical Co., Inc. - January 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/hisamitsu-pharmaceutical-co-inc/88a8e62b-b4d9-482e-87c3-e010e0dff817
Source feed: FDA_Inspections

> FDA Inspection 1006661 for Hisamitsu Pharmaceutical Co., Inc. on January 20, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006661
- Company Name: Hisamitsu Pharmaceutical Co., Inc.
- Inspection Date: 2017-01-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1272611 - 2025-07-11](https://www.keypedia.com/records/fda_inspections/hisamitsu-pharmaceutical-co-inc/c6d60d6e-c743-4379-a81f-fb304ce7d4b2)
- [FDA Inspection 1106332 - 2019-10-11](https://www.keypedia.com/records/fda_inspections/hisamitsu-pharmaceutical-co-inc/537dc8e0-4113-4fd3-b275-f29a4f94704a)

Company: https://www.keypedia.com/companies/hisamitsu-pharmaceutical-co-inc/274efe17-4e85-4f62-adfa-e2fff02f8ed3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c